ArticlemAbs

Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab).

Bas J M Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.